Author:
Berner Reinhard,Lehrnbecher Thomas
Publisher
Springer Berlin Heidelberg
Reference9 articles.
1. American Academy of Pediatrics (2009) Antimicrobials and related therapy. In: Peter G (Hrsg) Red book: Report of the Committee of Infectious Diseases, 27. Aufl. American Academy of Pediatrics, Elk Grove Village, S 738–763
2. De Pauw B, Walsh TJ, Donnelly JP et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813–1821
3. Deutsche Gesellschaft für Pädiatrische Infektiologie (2009) Handbuch Infektionen bei Kindern und Jugendlichen, 5. Aufl. Futuramed, München, S 81–121
4. Groll AH, Lehrnbecher T (2005) New antifungal drugs and the pediatric cancer patient: Current status of clinical development. Klin Padiatr 217:158–168
5. Groll AH, Castagnola E, Cesaro S et al (2012) ECIL 4 – Pediatric group: considerations for fungal diseases and antifungal treatment in children